Stage III Vulvar Cancer Completed Phase 2 Trials for Mitometh (DB12117)

IndicationStatusPhase
DBCOND0028772 (Stage III Vulvar Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs